BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin CH, Ho CM, Wu CH, Liang PC, Wu YM, Hu RH, Lee PH, Ho MC. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis. Surg Endosc 2020;34:5566-73. [PMID: 31993821 DOI: 10.1007/s00464-019-07357-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu K, Zheng H, Sui X, Liu B, Meng M, Feng Y, Zhu Q, Zhao X. Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score–matched study of long-term therapeutic outcomes. Eur Radiol. [DOI: 10.1007/s00330-022-09135-1] [Reference Citation Analysis]
2 Zhang C, Gao R, Guo S, Ning C, Li A, Wang X, Li S, Ding J, Kong X, Wang Q, Xu Y, Li J, Gao J, Wang S, Kong J, Ke S, Sun W. Anatomic resection versus radiofrequency ablation with an ablative margin ≥ 1.0 cm for solitary small hepatocellular carcinoma measuring ≤ 3 cm: Comparison of long-term outcomes using propensity score matching analysis. Eur J Radiol 2022;155:110498. [PMID: 36049409 DOI: 10.1016/j.ejrad.2022.110498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 . ABDOMEN/BECKEN – No-Touch-Radiofrequenzablation überzeugt bei kleinen hepatozellulären Karzinomen. Rofo 2022;194:598-601. [DOI: 10.1055/a-1692-1374] [Reference Citation Analysis]
4 Liu YW, Yen YH, Li WF, Wang CC, Lu SN, Kee KM, Yong CC, Cheng YF, Wang JH, Hu TH, Hung CH, Chen CH. Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East Asia. Surg Oncol 2022;42:101769. [PMID: 35468499 DOI: 10.1016/j.suronc.2022.101769] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Zheng H, Liu K, Yang Y, Liu B, Zhao X, Chen Y, Feng Y, Meng M, Tan X, Zhu Q. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score–matched study. Eur Radiol. [DOI: 10.1007/s00330-022-08537-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 He YZ, He K, Huang RQ, Liu LW, Ye SW, Qian JL, Peng P, Luo QJ, Wang ZL, Hu ZM. A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinoma. Sci Rep 2021;11:8275. [PMID: 33859298 DOI: 10.1038/s41598-021-87782-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
7 Liu C, Sun Y, Yang Y, Feng Y, Xie X, Qi L, Liu K, Wang X, Zhu Q, Zhao X. Gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis. Eur Radiol 2021;31:5840-50. [PMID: 33533990 DOI: 10.1007/s00330-021-07702-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Qi C, Gao H, Zhao Q, Zhang L. Computed Tomography-Guided Percutaneous Cryoablation for ‎ Subcardiac Hepatocellular Carcinoma: Safety, Efficacy, Therapeutic Results and Risk Factors for Survival Outcomes. Cancer Manag Res 2020;12:3333-42. [PMID: 32494197 DOI: 10.2147/CMAR.S250652] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]